易明医药(002826) - 2018 Q1 - 季度财报

Revenue and Profit - Revenue for Q1 2018 was CNY 90,734,178.49, representing a 15.69% increase compared to CNY 78,426,722.21 in the same period last year[8] - Net profit attributable to shareholders was CNY 6,148,774.24, up 10.68% from CNY 5,555,689.34 year-over-year[8] - The company's operating revenue for Q1 2018 was CNY 63,131,887.37, a decrease of 1.61% compared to CNY 64,161,577.50 in the same period last year[39] - The net profit attributable to the parent company was CNY 6,148,774.24, representing an increase of 10.67% from CNY 5,555,689.34 in Q1 2017[36] - The operating profit for the quarter was CNY 6,984,150.08, up from CNY 6,508,092.55, indicating a growth of 7.27% year-over-year[36] - The total profit for Q1 2018 was CNY 6,972,325.11, compared to CNY 6,404,058.69 in the previous year, marking an increase of 8.85%[36] Cash Flow - The net cash flow from operating activities was negative CNY 21,537,556.18, a decline of 192.59% compared to CNY 23,260,131.33 in the same period last year[8] - The cash flow from operating activities was CNY 92,977,315.68, compared to CNY 146,484,292.21 in the previous period, indicating a significant decrease[42] - Total cash inflow from operating activities was 102,165,943.06 yuan, while cash outflow was 123,703,499.24 yuan, resulting in a net cash outflow of 21,537,556.18 yuan[43] - Cash inflow from investment activities was 725,000.00 yuan, while cash outflow was 8,096,136.02 yuan, leading to a net cash outflow of 7,371,136.02 yuan[44] - Cash inflow from financing activities amounted to 10,000,000.00 yuan, with cash outflow of 50,263.89 yuan, resulting in a net cash inflow of 9,949,736.11 yuan[44] - The company reported a significant decrease in cash inflow from sales, totaling 61,047,490.77 yuan compared to 112,674,921.00 yuan in the previous period[46] - Total cash outflow from operating activities was 110,034,556.36 yuan, compared to 130,656,805.76 yuan in the previous period[47] - The net increase in cash and cash equivalents was -18,958,956.09 yuan, reflecting a decline in liquidity[44] Assets and Liabilities - Total assets at the end of the reporting period were CNY 733,493,209.95, a slight increase of 0.03% from CNY 733,291,272.90 at the end of the previous year[8] - Current liabilities totaled ¥120,255,465.27, a decrease from ¥126,139,552.45 in the previous period[29] - The company's cash and cash equivalents decreased to ¥223,026,756.62 from ¥255,349,338.30[31] - Accounts receivable decreased by 58.18% to ¥2,135,498.48 from ¥5,106,264.00, primarily due to the use or maturity of bank acceptance bills[16] - Inventory levels dropped to ¥1,509,675.03 from ¥2,474,229.79[31] - The total equity attributable to shareholders increased to ¥610,677,744.69 from ¥604,528,970.45[30] Non-Recurring Items - Net profit excluding non-recurring items decreased by 8.86% to CNY 5,036,893.51 from CNY 5,526,471.38 in the previous year[8] - Non-recurring gains and losses totaled CNY 1,111,880.73, primarily from asset disposals and government subsidies[9] - The company recorded an asset disposal gain of CNY 655,721.87, compared to CNY 85,742.02 in the previous year, showing a substantial increase[36] Future Outlook and Strategy - The estimated net profit for the first half of 2018 is projected to be between ¥15,000,000 and ¥25,000,000, representing a year-on-year change of -29.68% to 17.20%[19] - The company plans to enhance its marketing network and optimize its marketing team to achieve nationwide coverage[19] - R&D investments are expected to increase as the company continues to develop unique and high-quality products[19] - The company is focusing on expanding its market presence and developing new products and technologies[34] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 26,841[12] - The company reported a basic earnings per share of CNY 0.03, unchanged from the previous year[8] - The basic and diluted earnings per share remained stable at CNY 0.03, unchanged from the previous year[37] Financial Ratios - The weighted average return on equity was 1.01%, slightly up from 1.00% year-over-year[8] - The company reported a net profit margin improvement, with undistributed profits rising to ¥180,220,913.73 from ¥174,072,139.49[30] Financial Expenses - Financial expenses decreased by 143.39% to -¥108,690.79 from ¥250,508.96, as there were no discount interest expenses this period[16] - The tax expenses for the quarter were CNY 823,550.87, slightly down from CNY 848,369.35 in Q1 2017[36] Audit Status - The report was not audited, indicating that the figures presented are preliminary and subject to change[49]